Physiochemical and functional evaluation of the first-in-class anti-cancer IgE antibody drug, MOv18, through process development and good manufacturing practice production
Bax, H. J., Chauhan, J., McCraw, A. J., Grandits, M., Stavraka, C., Lentfer, H., Hillyer, T., Carroll, S., Vigor, K., Selkirk, C., Figini, M., Cheeseman, J., Urbanowicz, P. A., Gardner, R. A., Spencer, D. I. R., Westwood, N., Mellor, S., Spicer, J., Josephs, D. H. & Karagiannis, S. N., 2025, In: Mabs. 17, 1, 2451295.
Research output: Contribution to journal › Article › peer-review